AC
CRBU icon

AXQ Capital’s Caribou Biosciences CRBU Stock Holding History

AXQ Capital’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.6K Sell
12,249
-2,751
-18% -$5.44K ﹤0.01% 945
2026
Q1 		$28.5K Buy
+15,000
New +$25.7K ﹤0.01% 954
2024
Q2 		– Sell
-13,750
Closed -$70.7K – 498
2024
Q1 		$70.7K Buy
+13,750
New +$84.8K 0.02% 591

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AXQ Capital's CRBU Position: Q2 2026 in Review

AXQ Capital reduced its Caribou Biosciences (CRBU) stake by 18% in Q2 2026, selling an estimated $5.44K and leaving 12,249 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #945.

AXQ Capital first reported a position in CRBU in Q1 2024 and has held it in 3 quarters since. The position peaked at $70.7K in Q1 2024. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • AXQ Capital held 12,249 shares of Caribou Biosciences worth $21.6K as of Q2 2026.
  • AXQ Capital sold 2,751 Caribou Biosciences shares in Q2 2026, an estimated $5.44K.
  • Caribou Biosciences made up ﹤0.01% of AXQ Capital's portfolio in Q2 2026, its #945 holding.
  • AXQ Capital first reported a position in Caribou Biosciences in Q1 2024 and has held it in 3 quarters since.
  • AXQ Capital's Caribou Biosciences position peaked at $70.7K in Q1 2024.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.